Acetaminophen News and Research

The pain-reliever acetaminophen (also known as paracetomol) is one of the best-selling over-the-counter medications, used by more than 200 million Americans a year. It is sold under many brand names, including Tylenol, and is an ingredient in nearly 200 medications, both over-the-counter (such as Excedrin, Midol, NyQuil, and Sudafed) and prescription (such as Vicodin).

CONTOUR USB meter available for purchase through Walgreens online pharmacy

18. November 2009 00:13

Bayer's CONTOUR® USB meter, the first blood glucose monitor that connects directly to a PC or MAC -- providing users with instant access to information and trends about their blood sugar levels -- is now available for purchase through Walgreens online pharmacy and will soon also be available online through CVS and Walmart. [More]

e1cfb415-d8ad-4180-ad4b-590b11039c44|0|.0

Posted in: Device / Technology News

Tags: Acetaminophen, Ascorbic Acid, Blindness, CDC, Diabetes, Education, Gestational Diabetes, Glucose Metabolism, Insulin, Juvenile Diabetes, Kidney Disease, Metabolism, Nutrition, Obesity, Stroke, Type 1 Diabetes, Type 2 Diabetes

Tips on how to prevent household members from getting sick during flu season

18. November 2009 00:07

someone at home who has H1N1 (swine) flu, it is important for you to prevent other people in the house from getting sick, according to Gary Kalkut, MD, MPH, Senior Vice-President, Chief Medical Officer of Montefiore Medical Center. [More]

d51ff615-926f-4065-a2e4-6c97f15d92f9|0|.0

Posted in: Disease/Infection News

Tags: Acetaminophen, Antibiotic, Anti-Inflammatory, Aspirin, Cough, H1N1, Ibuprofen, Influenza, Kidney Disease

FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment

17. November 2009 01:49

NeurogesX, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Qutenza(TM) (capsaicin) 8% patch, the first and only product containing prescription strength capsaicin, for the management of neuropathic pain due to postherpetic neuralgia (PHN), the nerve pain which can follow shingles. [More]

6eb374e3-924e-48b6-b943-7f036aa791a4|1|5.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Acetaminophen, Blood Pressure, Capsaicin, Neuralgia, Opioids, Shingles, Sleep

Self-care tips for hemorrhoids from Mayo Clinic

16. November 2009 07:28

By about age 50, more than half of adults have dealt with hemorrhoids. The November issue of Mayo Clinic Health Letter covers home treatments that can relieve symptoms of this common and embarrassing problem. [More]

9465ab9b-175d-4e4b-8a93-4e668bc8d219|0|.0

Posted in: Medical Condition News

Tags: Acetaminophen, Aldosterone, Angiotensin, Blood Pressure, Cancer, Colonoscopy, Constipation, Defibrillator, Depression, Diabetes, Diarrhea, Heart Failure, Hydrocortisone, Ibuprofen, Inflammatory Bowel Disease, Lisinopril, Obesity, Parkinson's Disease, Pregnancy, Sleep, Sleep Apnea, Stress, Stroke

Home treatments for Hemorrhoids

16. November 2009 06:27

0b77e7bd-94e5-4a9d-94b5-9056b314d3d8|0|.0

Posted in: Medical Condition News

Tags: Acetaminophen, Cancer, Colonoscopy, Constipation, Diarrhea, Hydrocortisone, Ibuprofen, Inflammatory Bowel Disease, Obesity, Pregnancy

Priority Review of the NDA for intravenous acetaminophen extended by three months

15. November 2009 23:58

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for its Priority Review of the New Drug Application (NDA) for intravenous (IV) acetaminophen by three months. [More]

b696b343-bc91-49ff-82a0-b9a7862db308|0|.0

Posted in: Pharmaceutical News

Tags: Acetaminophen, Hospital, New Drug Application, Orthopedic, Pharmacology, Prescription Drug

Investors are betting on upcoming medical study results of BioElectronics, says BioMedReports

12. November 2009 03:45

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, reports that investors are betting that BioElectronics' (PINKSHEETS: BIEL) upcoming medical study results will be significant. [More]

17a41ce6-d8d0-4ac1-ac03-6f5d85fe83d0|0|.0

Posted in: Business / Finance | Pharmaceutical News

Tags: Acetaminophen, Investment

New FDA program targets drug dosage errors

6. November 2009 00:20

Federal Drug Administration Commissioner Margaret A. Hamburg announced a new "Safe Use" program for drugs on Wednesday. [More]

59df124f-c3cd-4cb2-9da3-5255df5aa8a8|0|.0

Posted in: Pharmaceutical News

Tags: Acetaminophen, Morphine

Cadence Pharmaceuticals reports net loss of $11.4 million for three months ended September 30, 2009

5. November 2009 23:14

Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today reported financial results for the three and nine months ended September 30, 2009. [More]

06fc70c0-23b9-4ab1-9087-add67538fdcc|0|.0

Posted in: Business / Finance

Tags: Acetaminophen, Hospital, New Drug Application

FDA announces new initiative program to reduce risks from inappropriate medication use

5. November 2009 02:06

The U.S. Food and Drug Administration today announced the Safe Use Initiative, a program aimed at reducing the likelihood of preventable harm from medication use. [More]

23ba5328-f511-4802-b615-75862a7b42b2|0|.0

Posted in: Healthcare News

Tags: Acetaminophen

Commonly used pain reliever may be associated with asthma in children and adults

5. November 2009 01:38

New research shows that the widely used pain reliever acetaminophen may be associated with an increased risk of asthma and wheezing in both children and adults exposed to the drug. Researchers from the University of British Columbia, Vancouver, BC, Canada, conducted a systematic review and metaanalysis of 19 clinical studies (total>The analysis showed that the pooled odds ratio (odds ratio for all studies combined) for asthma among users of acetaminophen was 1.63. [More]

02e0e41c-ca72-4a69-8b40-39428cf66cf8|0|.0

Posted in: Child Health News | Medical Condition News

Tags: Acetaminophen, Asthma

Common pain killers may blunt the effect of flu shots

4. November 2009 00:21

With flu vaccination season in full swing, research from the University of Rochester Medical Center cautions that use of many common pain killers - Advil, Tylenol, aspirin - at the time of injection may blunt the effect of the shot and have a negative effect on the immune system. [More]

7efa0299-8c8c-4197-b1e8-b0e5e96cc250|0|.0

Posted in: Pharmaceutical News

Tags: Acetaminophen, Antibody, Anti-Inflammatory, Arthritis, Aspirin, Cell, Ibuprofen, Immunology, Influenza, Pediatrics, Stress, Stroke, Vaccine, Virus

Cumberland Pharmaceuticals and Phebra team up to commercialize Caldolor injection

30. October 2009 00:00

Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor® (ibuprofen) Injection in Australia and New Zealand. [More]

63fc851a-3c86-4967-94bb-f2b25e6f92ea|0|.0

Posted in: Pharmaceutical News

Tags: Acetaminophen, Anti-Inflammatory, Aspirin, Asthma, Blood Pressure, Gastroenterology, Heart Failure, Hospital, Hypersensitivity, Ibuprofen, Morphine, Palliative Care, Ulcer, Urticaria

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

20. October 2009 05:40

Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study. [More]

003e4c23-c045-4e9b-9be9-62e458918f8f|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Acetaminophen, Anemia, Biomarker, Bone, Bone Marrow, Cancer, Cell, Chemotherapy, Chromosome, Chronic Myeloid Leukemia, Congestive Heart Failure, Constipation, Contraception, Diarrhea, Edema, Erythromycin, Gleevec, Haloperidol, Headache, Heart Failure, Hematology, Hyperglycemia, Hyponatremia, Hypothyroidism, Imatinib Mesylate, Immunosuppression, Leukaemia, Leukemia, Leukopenia, Metabolism, Methadone, Myeloid Leukemia, Nausea, Neutropenia, Nursing, Oncology, Pancreatitis, Pathology, Pneumonia, Pregnancy, Thrombocytopenia, Vomiting, Warfarin

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

20. October 2009 02:38

Cumberland Pharmaceuticals Inc. announced today that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced less pain with 800 mg of intravenous ibuprofen every six hours compared to morphine alone. [More]

8908524f-b39a-47fd-bcc2-8534e4eb5474|0|.0

Posted in: Drug Trial News | Medical Research News

Tags: Acetaminophen, Analgesia, Anesthesiology, Aspirin, Asthma, Blood Pressure, Gastroenterology, Heart Failure, Hospital, Hypersensitivity, Ibuprofen, Morphine, Orthopedic, Palliative Care, Sports Medicine, Ulcer, Urticaria

<< Previous posts

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

Free!

Recent Comments

Twitter

Information

Acetaminophen News and Research

CONTOUR USB meter available for purchase through Walgreens online pharmacy

Tips on how to prevent household members from getting sick during flu season

FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment

Self-care tips for hemorrhoids from Mayo Clinic

Home treatments for Hemorrhoids

Priority Review of the NDA for intravenous acetaminophen extended by three months

Investors are betting on upcoming medical study results of BioElectronics, says BioMedReports

New FDA program targets drug dosage errors

Cadence Pharmaceuticals reports net loss of $11.4 million for three months ended September 30, 2009

FDA announces new initiative program to reduce risks from inappropriate medication use

Commonly used pain reliever may be associated with asthma in children and adults

Common pain killers may blunt the effect of flu shots

Cumberland Pharmaceuticals and Phebra team up to commercialize Caldolor injection

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Recent Articles

Free!

Recent Comments

Twitter

Information

Acetaminophen News and Research

Medical News Cloud

Recent Articles